Prevention of hemolytic disease of the fetus and newborn by anti-D-immunoprophylaxis
- Autores: Pavlova N.G.1,2,3
-
Afiliações:
- I.P. Pavlov First St. Petersburg State Medical University
- St. Petersburg State University
- Maternity Hospital No. 6 in St. Petersburg
- Edição: Nº 9 (2017)
- Páginas: 138-143
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248060
- DOI: https://doi.org/10.18565/aig.2017.9.138-43
- ID: 248060
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Objective. To analyze the data available in the current literature regarding the prevention of hemolytic disease of the fetus and newborn by anti-D immunoprophylaxis. Material and methods. The review included the data of foreign and Russian articles published in the past 10years and found in PubMed on this topic. Results. The review presents the epidemiology and pathogenesis of sensitization in Rh-negative pregnant women having an Rh-positive fetus, the need for immunoprophylaxis of hemolytic disease of the fetus and newborn, indications, regimens, and the required volumes of immunoprophylaxis in different obstetric situations, and the choice of an immunoglobulin. Conclusion. Understanding the pathogenetic bases for the immunoprophylaxis of D-sensitization, as well as steady execution of clinical guidelines for the management of patients having pregnancy in rhesus-incompatibility marriage will assist in improving perinatal indicators and reproductive health in women.
Texto integral
Sobre autores
Natalia Pavlova
I.P. Pavlov First St. Petersburg State Medical University; St. Petersburg State University; Maternity Hospital No. 6 in St. Petersburg
Email: ngp05@yandex.ru
MD, Professor of the Department of Obstetrics, Gynecology and Reproduction; Professor of the Department of Obstetrics, Gynecology and Reproduction; Deputy Chief Physician for Perinatology of Maternity Hospital No. 6 in St. Petersburg
Bibliografia
- Moise K.J. Jr. Management of Rhesus alloimmunization in pregnancy. Obstet. Gynecol. 2002; 100(3): 600-11.
- Bowman J.M. Thirty-five years of Rh prophylaxis. Transfusion. 2003; 43(12): 1661-6.
- Ismail K.M., Martin W.L., Ghosh S., Whittle M.J., Kilby M.D. Etiology and outcome of hydrop fetalis. J. Matern. Fetal Med. 2001; 10(3): 175-81.
- Павлова Н.Г. Анти-D-иммунопрофилактика. Журнал акушерства и женских болезней. 2015; 64(3): 52-7. [Pavlova N.G. Anti-D-immunoprophylaxis. Zhurnal akusherstva i zhenskih bolezney. 2015; 64(3): 52-7. (in Russian)]
- National Institute for Health and Clinical Excellience. Rutine antenatal anti-D prophylaxis for women who are rhesus D negative (TA156). London: NICE; 2008. Available at: http://uidance.nice.org.uk/TA156
- Woodrow J.C., Clarke C.A., Donohue W.T.A., Finn R., McConnell R.B., Sheppard P.M. et al. Prevention of Rh-haemolytic disease: a third report. Br. Med. J. 1965; 1(5430): 279-83.
- Айламазян Э.К., Павлова Н.Г. Изоиммунизация при беременности. СПб.: Издательство Н-Л; 2012: 143-53. [Aylamazyan E.K., Pavlova N.G. Isoimmunization during pregnancy. St. Petersburg: Publisher NL; 2012: 143-53. (in Russian)]
- Fung Kee Fung K., Eason E., Crane J., Armson A., De La Ronde S., Farine D. et al.; Maternal-Fetal Medicine Committee, Genetics Committee. Prevention of Rh alloimmunization. J. Obstet. Gynaecol. Can. 2003; 25(9): 765-73.
- Bennardello F., Coluzzi S., Curciarello G., Todros T., Villa S.; Italian Society of Transfusion Medicine and Immunohaematology (SIMTI) and Italian Society of Gynaecology and Obstetrics (SIGO) working group. Recommendation for the prevention and treatment of haemolytic disease of the foetus and newborn. Blood Transfus. 2015; 13(1): 109-34. doi: 10.2450/2014.0119-14.
- Конопляников А.Г., Павлова Н.Г. Изосерологическая несовместимость крови матери и плода. Гемолитическая болезнь плода и новорожденного. В кн.: Савельева Г.М., Сухих Г.Т., В.Н. Серов В.Н., В.Е. Радзинский В.Е., ред. Акушерство. Национальное руководство. М.: ГЭОТАР-Медиа; 2015: 324-34. [Konoplyanikov A.G., Pavlova N.G. Isoserological incompatibility of blood of mother and fetus. Hemolytic disease of the fetus and newborn. In: Saveleva G.M., Sukhikh G.T., Serov V.N., Radzinsky V.E., ed. Obstetrics. National guideline. Moscow: GEOTAR-Media; 2015: 324-34. (in Russian)]
- Rodeck C.H., Sheldrake A., Beatie B., Whittle M.J. Maternal serum alphafetoprotein after placental damage in chorionic villus sampling. Lancet. 1993; 341(8843): 500.
- Резус сенсибилизация. Гемолитическая болезнь плода. Клинические рекомендации (протокол). М.; 2017. 16с. [Rhesus sensitization. Hemolytic disease of the fetus. Clinical recommendations (protocol). Moscow; 2017. 16p. (in Russian)]
Arquivos suplementares
